Head and neck cancer trial tests if less frequent chemo doses reduce harsh side effects
Disease control
Ongoing
This study is testing two different schedules for giving the chemotherapy drug cisplatin alongside radiation for head and neck cancer. It aims to see if getting the drug once every three weeks causes fewer severe side effects than getting it weekly, while still being effective at…
Phase: PHASE2 • Sponsor: Susanne Arnold • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC